Jeffrey Curtis, MD, MS, MPH

University of Alabama at Birmingham
Hoover, AL, United States

n/a

Disclosure information not submitted.

Presentation(s):

• 0060: Lower Healthcare Costs for Commercially Insured Patients with Rheumatoid Arthritis in Remission

  Saturday, November 12, 2022
  1:00 PM – 3:00 PM Eastern Time

• 0083: COVID-19 Vaccine Uptake and Reasons for Hesitancy in a Large Rheumatology Practice Network

  Saturday, November 12, 2022
  1:00 PM – 3:00 PM Eastern Time

• 0195: Acceptance of Virtual Reality for Managing Their Disease Among People with Rheumatologic Conditions with and Without Prior Experience Using Virtual Reality

  Saturday, November 12, 2022
  1:00 PM – 3:00 PM Eastern Time

• 0509: Guselkumab Provides Sustained Improvements in Work Productivity and Daily Activity in Patients with Active Psoriatic Arthritis Through 2 Years of DISCOVER-2

  Saturday, November 12, 2022
  3:45 PM – 3:55 PM Eastern Time

• Patient Self-Assessment and Remote Patient Monitoring

  Sunday, November 13, 2022
  10:50 AM – 10:55 AM Eastern Time

• Panel Discussion

  Sunday, November 13, 2022
  11:00 AM – 11:30 AM Eastern Time

• 1199: Validation of New Medication User Definitions in Single-Specialty EHR Data

  Sunday, November 13, 2022
  1:00 PM – 3:00 PM Eastern Time

• 1547: Effectiveness of Interleukin-6 Receptor Inhibitors for Polymyalgia Rheumatica

  Sunday, November 13, 2022
  1:00 PM – 3:00 PM Eastern Time

• 1585: Decreased Discontinuation and Switching of B/tsDMARD Therapy in RA Patients When Treatment Is Aligned with a Molecular Signature Response Classifier: An Analysis from the Study to Accelerate Information of Molecular Signatures (AIMS)

  Sunday, November 13, 2022
  3:00 PM – 3:10 PM Eastern Time

• 1850: Guselkumab Provides Sustained Improvements in Health-Related Quality of Life in Patients with Active Psoriatic Arthritis Through 2 Years of DISCOVER-2

  Monday, November 14, 2022
  1:00 PM – 3:00 PM Eastern Time

• 2199: Primary Non-adherence to Biologics and Immunomodulatory Therapies for Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis Using Linked EHR and Pharmacy Claims Data

  Monday, November 14, 2022
  3:30 PM – 3:40 PM Eastern Time